Sun Pharma Advanced Research Company Limited (BOM:532872)
India flag India · Delayed Price · Currency is INR
134.95
-1.95 (-1.42%)
At close: Feb 12, 2026

BOM:532872 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
42,86948,000119,52158,20380,73437,250
Market Cap Growth
-20.01%-59.84%105.35%-27.91%116.74%47.38%
Enterprise Value
47,02648,951116,00260,08881,45538,052
Last Close Price
132.05148.00369.95179.45296.85141.70
PS Ratio
80.6866.88158.2124.3858.8214.73
PB Ratio
-12.44-22.1295.0411.35258.55-22.14
P/TBV Ratio
--143.9311.94995.49-
EV/Sales Ratio
88.5068.21153.5525.1759.3515.04
Debt / Equity Ratio
-1.21-1.240.490.032.54-1.40
Net Debt / Equity Ratio
-1.21-1.23-0.76-0.752.12-1.31
Net Debt / EBITDA Ratio
-1.82-0.820.241.80-0.35-1.61
Net Debt / FCF Ratio
--0.720.214.58-0.28-1.40
Asset Turnover
-0.170.110.430.541.01
Inventory Turnover
-17.6028.6426.4325.1520.05
Quick Ratio
-0.050.812.470.250.14
Current Ratio
-0.071.022.540.420.27
Return on Equity (ROE)
---121.28%-81.83%--
Return on Assets (ROA)
--49.05%-38.26%-25.18%-48.08%-36.26%
Return on Capital Employed (ROCE)
-862.30%-164.70%-34.30%-180.50%3978.90%
Earnings Yield
-6.25%-7.14%-3.24%-3.82%-2.52%-4.06%
FCF Yield
--7.72%-3.81%-1.45%-2.98%-4.24%
Buyback Yield / Dilution
-0.02%--13.99%-8.19%-0.42%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.